All News about Spectrum Pharmaceuticals, Inc. - Common Stock![]() ![]() Via Benzinga
![]() ![]()
Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst
September 23, 2022
Via Benzinga
![]()
After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding
September 23, 2022
Via Benzinga
![]() ![]()
FDA's Adcomm Gives Thumbs Down To Spectrum Pharmaceuticals' Lung Cancer Candidate
September 23, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Via Benzinga
![]()
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|